Home

Commercial Contradiction Dim ch1 resin Indoors Phalanx Email

Antibody interfaces revealed through structural mining - ScienceDirect
Antibody interfaces revealed through structural mining - ScienceDirect

Purolite & Repligen Launch New CH1 Affinity Resin for Specialized mAb  Purification
Purolite & Repligen Launch New CH1 Affinity Resin for Specialized mAb Purification

CaptureSelect™ CH1-XL Affinity Matrix
CaptureSelect™ CH1-XL Affinity Matrix

Ion Exchange Resin Manufacturer | Purolite | www.purolite.com
Ion Exchange Resin Manufacturer | Purolite | www.purolite.com

What is a nanobody?
What is a nanobody?

Protein G, L resin
Protein G, L resin

High-Throughput Generation of Bipod (Fab × scFv) Bispecific Antibodies  Exploits Differential Chain Expression and Affinity Capture | Scientific  Reports
High-Throughput Generation of Bipod (Fab × scFv) Bispecific Antibodies Exploits Differential Chain Expression and Affinity Capture | Scientific Reports

OH 33 / CH-1 - Ebalta
OH 33 / CH-1 - Ebalta

An Alternative to Protein A for Efficient Capture of a Bispecific Antibody  - Chamow and Associates
An Alternative to Protein A for Efficient Capture of a Bispecific Antibody - Chamow and Associates

Purolite and Repligen announce the commercial launch of a novel CH1  affinity resin for the purification of specialized mAbs | World Pharma Today
Purolite and Repligen announce the commercial launch of a novel CH1 affinity resin for the purification of specialized mAbs | World Pharma Today

Purolite and Repligen to commercially launch novel CH1 affinity resin
Purolite and Repligen to commercially launch novel CH1 affinity resin

Novel Affinity Resins Enabling the Purification of Next Generation Antibody  Fragments
Novel Affinity Resins Enabling the Purification of Next Generation Antibody Fragments

A bispecific IgG format containing four independent antigen binding sites |  Scientific Reports
A bispecific IgG format containing four independent antigen binding sites | Scientific Reports

Accelerating Antibody Drug Development With Affinity Purification Poster |  Technology Networks
Accelerating Antibody Drug Development With Affinity Purification Poster | Technology Networks

Bispecific Antibodies: Downstream Purification - BioProcess  InternationalBioProcess International
Bispecific Antibodies: Downstream Purification - BioProcess InternationalBioProcess International

High-Throughput Generation of Bipod (Fab × scFv) Bispecific Antibodies  Exploits Differential Chain Expression and Affinity Capture | Scientific  Reports
High-Throughput Generation of Bipod (Fab × scFv) Bispecific Antibodies Exploits Differential Chain Expression and Affinity Capture | Scientific Reports

Affinity Chromatography Applications with Single-Domain Antibodies -  BioProcess InternationalBioProcess International
Affinity Chromatography Applications with Single-Domain Antibodies - BioProcess InternationalBioProcess International

Purification of Fab, scFv, and dAb antibody fragments | Cytiva
Purification of Fab, scFv, and dAb antibody fragments | Cytiva

Bispecific Antibodies: Downstream Purification - BioProcess  InternationalBioProcess International
Bispecific Antibodies: Downstream Purification - BioProcess InternationalBioProcess International

Protein G, L resin
Protein G, L resin

Thermo Fisher Scientific
Thermo Fisher Scientific

Repligen on X: "AVIPure® CH1 Affinity Resin is NOW available! Our new CH1  affinity resin offers the highest capacity and is the most reusable resin  on the market. Request a sample today:
Repligen on X: "AVIPure® CH1 Affinity Resin is NOW available! Our new CH1 affinity resin offers the highest capacity and is the most reusable resin on the market. Request a sample today:

Affinity Resins | Repligen
Affinity Resins | Repligen

Novel Affinity Resins Enabling the Purification of Next Generation Antibody  Fragments
Novel Affinity Resins Enabling the Purification of Next Generation Antibody Fragments

Novel Affinity Resins Enabling the Purification of Next Generation Antibody  Fragments
Novel Affinity Resins Enabling the Purification of Next Generation Antibody Fragments